Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Martha Barron
Research Program Administration Officer III
Medicine
Overview
Research
More
Collaboration
(6)
Tirdad Zangeneh
Mutual work: 2 Proposals﹒2 Grants
Collaboration Details
Joshua Malo
Mutual work: 1 Proposal﹒1 Grant
Collaboration Details
James Liao
Mutual work: 1 Supervisor
Collaboration Details
Jose Elizondo
Mutual work: 3 Grants﹒3 Proposals
Collaboration Details
Mohanad Al-Obaidi
Mutual work: 2 Proposals
Collaboration Details
Page 1 of 2
Previous page
Next page
Grants
(5)
A Phase 2/3, Randomized, Double-blind, Placebo-controlled, Multicenter, Prospective Study to Assess the Efficacy, Safety, and Pharmacokinetics of Orally Administered Epetraborole in Patients with Trea
Active
·
2023
·
$0 / $301.3K
·
External
clinical trials,
pharmacokinetics,
drug efficacy,
safety assessment
A Phase 3, Multicenter, Prospective, Randomized, Double-blind Study of Two Treatment Regimens for Candidemia and/or Invasive Candidiasis: Intravenous Echinocandin followed by Oral Ibrexafungerp versus
Active
·
2023
·
$0 / $243.3K
·
External
candidemia,
invasive candidiasis,
treatment regimens,
echinocandin,
ibrexafungerp
A Phase 1b/2a, Randomized, Double-Blind, Placebo Controlled, Multiple Ascending Dose Escalation Study of the Safety, Tolerability, and Efficacy of Intravenous AP-SA02 as an Adjunct to Best Available A
Active
·
2023
·
$0 / $240.2K
·
External
clinical trial,
drug safety,
intravenous therapy
Improved Serological Diagnosis of Coccidiodomycosis
Active
·
2023
·
$0 / $74K
·
External
diagnostic methods,
infectious diseases,
serological testing,
fungal infections,
medical mycology
A5332: Randomized Trial to Prevent Vascular Events in HIV - REPRIEVE
Active
·
2023
·
$0 / $8.9K
·
External
hiv,
vascular events,
randomized trial,
prevention,
reprieve
